The safety and efficacy of subcutaneous birch pollen immunotherapy – a one-year, randomised, double-blind, placebo-controlled study

Authors


Uffe Bødtger MD
Allergy Unit TA 7511
National University Hospital
Blegdamsvej 9
DK-2100 Copenhagen Ø
Denmark

Ancillary